Stelvio Therapeutics Company
Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Their team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics.
(Reupload).png)
Technology:
Personalised Medicine
Industry:
Early Drug Development
Headquarters:
San Diego, California, United States
Founded Date:
2017-03-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
2
Estimated Revenue:
Less than $1M
Last Funding Date:
2017-05-05
Last Funding Type:
Seed
Register and Claim Ownership